The world’s first stereotactic radiotherapy system optimized for treating breast cancer.
With GammaPod™, radiation oncologists can be at the forefront of a new era in cancer care by providing Stereotactic Partial Breast Irradiation (S-PBI), an advanced type of SBRT, for breast cancer. The delivery of higher doses in one or several large fractions differentiates stereotactic radiotherapy from conventional techniques.
Born out of the vision to extend the dosimetric benefits of stereotactic radiotherapy to patients undergoing breast conserving treatment, GammaPod™ is a new precision tool with the potential to change the way early stage breast cancer is managed.
The shift to noninvasive external beam treatments with highly conformal dose distributions delivered in less time has the potential to drive value for all stakeholders.
CREATING NEW POSSIBILITIES FOR BREAST CANCER TREATMENT
With GammaPod™, radiation oncologists have a new tool for delivering ultra-accelerated courses of adjuvant stereotactic partial breast irradiation, reducing tumor bed boosts to a single fraction for patients receiving whole breast irradiation and neoadjuvant treatments at ablative dose levels.
4 Simple steps enabling
Single-Day Adaptive Treatments